{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:37:48Z","timestamp":1777963068123,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.4158\/ep.6.3.272","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T23:35:58Z","timestamp":1365204958000},"page":"272-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Inflammation, Insulin Resistance, Infection, Diabetes, and Atherosclerosis"],"prefix":"10.1016","volume":"6","author":[{"given":"David S.H.","family":"Bell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.6.3.272_bb0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.CIR.92.3.657","article-title":"Coronary plaque disruption","volume":"92","author":"Falk","year":"1995","journal-title":"Circulation."},{"issue":"Suppl L","key":"10.4158\/EP.6.3.272_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/eurheartj\/16.suppl_L.3","article-title":"Acute coronary thrombosis\u2014the role of plaque disruption and its initiation and prevention","volume":"16","author":"Davies","year":"1995","journal-title":"Eur Heart J."},{"key":"10.4158\/EP.6.3.272_bb0015","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/oxfordjournals.aje.a008963","article-title":"Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study: Multiple Risk Factor Intervention Trial","volume":"144","author":"Kuller","year":"1996","journal-title":"Am J Epidemiol."},{"key":"10.4158\/EP.6.3.272_bb0020","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/01.ATV.17.6.1121","article-title":"Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project","volume":"17","author":"Tracy","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.4158\/EP.6.3.272_bb0025","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.CIR.98.8.731","article-title":"Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation."},{"key":"10.4158\/EP.6.3.272_bb0030","first-page":"462","article-title":"Pepys MB (European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group)","volume":"349","author":"Haverkate","year":"1997","journal-title":"Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet."},{"key":"10.4158\/EP.6.3.272_bb0035","doi-asserted-by":"crossref","first-page":"933","DOI":"10.7326\/0003-4819-130-11-199906010-00018","article-title":"Evaluating novel cardiovascular risk factors: can we better predict heart attacks?","volume":"130","author":"Ridker","year":"1999","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.6.3.272_bb0040","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men [published erratum appears in N Engl J Med. 1997;337:356]","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.6.3.272_bb0045","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.98.9.839","article-title":"(Cholesterol and Recurrent Events [CARE] Investigators). Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation."},{"key":"10.4158\/EP.6.3.272_bb0050","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199509073331003","article-title":"Effect of pravastatin on outcomes after cardiac transplantation","volume":"333","author":"Kobashigawa","year":"1995","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.6.3.272_bb0055","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1056\/NEJM199010043231404","article-title":"Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia: report of the Program on the Surgical Control of the Hyperlipidemias","volume":"323","author":"Buchwald","year":"1990","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.6.3.272_bb0060","doi-asserted-by":"crossref","first-page":"956","DOI":"10.7326\/0003-4819-118-12-199306150-00008","article-title":"Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature","volume":"118","author":"Ernst","year":"1993","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.6.3.272_bb0065","first-page":"138","article-title":"Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging","volume":"70","author":"Vlassara","year":"1994","journal-title":"Lab Invest."},{"key":"10.4158\/EP.6.3.272_bb0070","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1056\/NEJM199604113341504","article-title":"Hyperinsulinemia as an independent risk factor for ischemic heart disease","volume":"334","author":"Despres","year":"1996","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.6.3.272_bb0075","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1007\/s001250050822","article-title":"NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X","volume":"40","author":"Pickup","year":"1997","journal-title":"Diabetologia."},{"key":"10.4158\/EP.6.3.272_bb0080","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/0026-0495(89)90038-3","article-title":"Increased levels of acute-phase serum proteins in diabetes","volume":"38","author":"McMillan","year":"1989","journal-title":"Metabolism."},{"key":"10.4158\/EP.6.3.272_bb0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0167-5699(94)90138-4","article-title":"The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein","volume":"15","author":"Steel","year":"1994","journal-title":"Immunol Today."},{"key":"10.4158\/EP.6.3.272_bb0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2796.1995.tb00895.x","article-title":"Coronary heart disease in diabetes mellitus: three new risk factors and a unifying hypothesis","volume":"238","author":"Yudkin","year":"1995","journal-title":"J Intern Med."},{"key":"10.4158\/EP.6.3.272_bb0095","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2337\/diacare.15.10.1245","article-title":"Hyperfibrinogenemia: an important risk factor for vascular complications in diabetes","volume":"15","author":"Ganda","year":"1992","journal-title":"Diabetes Care."},{"key":"10.4158\/EP.6.3.272_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60532-5","article-title":"Interleukin-6 in biology and medicine","volume":"54","author":"Akira","year":"1993","journal-title":"Adv Immunol."},{"key":"10.4158\/EP.6.3.272_bb0105","first-page":"724","article-title":"Biologic activities and mechanisms of action of tumor necrosis factor-alpha\/cachectin","volume":"64","author":"Jaattela","year":"1991","journal-title":"Lab Invest."},{"key":"10.4158\/EP.6.3.272_bb0110","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2796.1995.tb01229.x","article-title":"Immunological mechanisms in atherosclerosis","volume":"238","author":"Yokota","year":"1995","journal-title":"J Intern Med."},{"key":"10.4158\/EP.6.3.272_bb0115","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.2337\/diab.43.11.1271","article-title":"Tumor necrosis factor alpha: a key component of the obesity-diabetes link","volume":"43","author":"Hotamisligil","year":"1994","journal-title":"Diabetes."},{"key":"10.4158\/EP.6.3.272_bb0120","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2337\/diab.43.5.613","article-title":"Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: therapeutic intervention by immunostimulation?","volume":"43","author":"Rabinovitch","year":"1994","journal-title":"Diabetes."},{"key":"10.4158\/EP.6.3.272_bb0125","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/BF00404074","article-title":"Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus","volume":"36","author":"Groop","year":"1993","journal-title":"Diabetologia."},{"key":"10.4158\/EP.6.3.272_bb0130","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0140-6736(99)01046-6","article-title":"Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities Study): a cohort study","volume":"353","author":"Schmidt","year":"1999","journal-title":"Lancet."},{"key":"10.4158\/EP.6.3.272_bb0135","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0140-6736(96)09424-X","article-title":"Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link?","volume":"349","author":"Vallance","year":"1997","journal-title":"Lancet."},{"key":"10.4158\/EP.6.3.272_bb0140","doi-asserted-by":"crossref","first-page":"9010","DOI":"10.1073\/pnas.87.22.9010","article-title":"Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging","volume":"87","author":"Kirstein","year":"1990","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.4158\/EP.6.3.272_bb0145","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(88)90741-6","article-title":"Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction","volume":"2","author":"Saikku","year":"1988","journal-title":"Lancet."},{"key":"10.4158\/EP.6.3.272_bb0150","first-page":"3148","article-title":"Chlamydia pneumoniae and acute arterial thrombotic disease [letter]","volume":"92","author":"Cook","year":"1995","journal-title":"Circulation."},{"key":"10.4158\/EP.6.3.272_bb0155","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0140-6736(97)03079-1","article-title":"Chronic infections and coronary heart disease: is there a link?","volume":"350","author":"Danesh","year":"1997","journal-title":"Lancet."},{"key":"10.4158\/EP.6.3.272_bb0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1017\/S0950268897008303","article-title":"Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not","volume":"120","author":"Ossewaarde","year":"1998","journal-title":"Epidemiol Infect."},{"key":"10.4158\/EP.6.3.272_bb0165","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-116-4-273","article-title":"Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study","volume":"116","author":"Saikku","year":"1992","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.6.3.272_bb0170","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/oxfordjournals.eurheartj.a014934","article-title":"Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland","volume":"17","author":"Miettinen","year":"1996","journal-title":"Eur Heart J."},{"key":"10.4158\/EP.6.3.272_bb0175","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/bmj.318.7190.1035","article-title":"Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly Prospective Heart Disease Study","volume":"318","author":"Strachan","year":"1999","journal-title":"BMJ."},{"key":"10.4158\/EP.6.3.272_bb0180","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0735-1097(98)00016-3","article-title":"Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease","volume":"31","author":"Maass","year":"1998","journal-title":"J Am Coll Cardiol."},{"key":"10.4158\/EP.6.3.272_bb0185","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/01.CIR.98.7.628","article-title":"Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis","volume":"98","author":"Davidson","year":"1998","journal-title":"Circulation."},{"key":"10.4158\/EP.6.3.272_bb0190","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/01.CIR.98.4.300","article-title":"Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression","volume":"98","author":"Kol","year":"1998","journal-title":"Circulation."},{"key":"10.4158\/EP.6.3.272_bb0195","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/bmj.312.7038.1061","article-title":"C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study","volume":"312","author":"Mendall","year":"1996","journal-title":"BMJ."},{"key":"10.4158\/EP.6.3.272_bb0200","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/01.CIR.96.2.404","article-title":"Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction","volume":"96","author":"Gupta","year":"1997","journal-title":"Circulation."},{"key":"10.4158\/EP.6.3.272_bb0205","first-page":"404","article-title":"Mautner B (ROXIS Study Group)","volume":"350","author":"Gurfinkel","year":"1997","journal-title":"Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. Lancet."},{"key":"10.4158\/EP.6.3.272_bb0210","doi-asserted-by":"crossref","first-page":"9889","DOI":"10.1016\/S0021-9258(17)36966-1","article-title":"Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors\/binding proteins","volume":"269","author":"Yan","year":"1994","journal-title":"J Biol Chem."},{"key":"10.4158\/EP.6.3.272_bb0215","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.3259727","article-title":"Cachectin\/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling","volume":"240","author":"Vlassara","year":"1988","journal-title":"Science."},{"key":"10.4158\/EP.6.3.272_bb0220","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM199109193251202","article-title":"Advanced glycosylation end products in patients with diabetic nephropathy","volume":"325","author":"Makita","year":"1991","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.6.3.272_bb0225","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s001250051162","article-title":"Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation","volume":"42","author":"Schalkwijk","year":"1999","journal-title":"Diabetologia."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20413515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20413515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/P0J0BM6Y9Q8PM0TV.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:40:26Z","timestamp":1761514826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20413515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["S1530891X20413515"],"URL":"https:\/\/doi.org\/10.4158\/ep.6.3.272","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2000,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation, Insulin Resistance, Infection, Diabetes, and Atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.6.3.272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}